Falcon Capital Acquisition Corp.
FCACU
NASDAQ Capital Market9.55
USD
-0.72
- -
CIK
0001816233
Return %
Stock
S&P500
1Y
- -
18.02
3Y
-7.82
64.11
5Y
-7.82
72.15
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Alan Geoffrey Mnuchin
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 660 Madison Avenue New York City NY United States of America
- IPO Date
- Sep 3, 2020
- CIK
- 0001816233
- Website
- falconequityinvestors.com
- Similar Companies
- Business
- Falcon Capital Acquisition Corp. primarily operates as a special purpose acquisition company (SPAC) incorporated in 2020 and headquartered in New York, New York. The company’s core business involves facilitating mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or other business combinations with private operating companies. Falcon Capital Acquisition Corp. itself does not directly manufacture or sell commercial products or services but acts as an investment vehicle to create long-term value through strategic acquisitions and management. A significant recent development for Falcon Capital Acquisition Corp. was its business combination with Sharecare, Inc., a digital health company, which was approved by shareholders and completed in mid-2021. This transaction resulted in a reverse merger where Falcon Capital Acquisition Corp. effectively transitioned to Sharecare, Inc. Sharecare began trading on Nasdaq under the ticker "SHCR" following the merger. The transaction included substantial funding including cash, PIPE investments, and strategic partnerships notably with Anthem, Inc., aimed at enhancing Sharecare’s digital health platform, product development, and expansion across healthcare engagement solutions. The latest major changes revolve around this reverse merger, the substantial infusion of gross proceeds exceeding $571 million to support product innovation in digital health, and the collaboration to develop affordable healthcare solutions. Falcon Capital Acquisition Corp.’s business activities post-merger focus on supporting healthcare technology and digital health platform services worldwide through Sharecare. The company originally targets broad private equity investment and acquisition activities focusing on high-growth sectors, leveraging strategic partnerships and capital market vehicles to transition private companies to public markets. Overall, Falcon Capital Acquisition Corp. serves as an acquisition platform specializing in creating value via strategic business combinations, most notably the completed merger with Sharecare, marking its operational shift into digital health service markets following its founding in 2020. The company operates extensively within North America and aims to support innovation and expansion in healthcare through capital investments and synergistic collaborations.
Falcon Capital Acquisition (OTCMKTS:FCACU) Trading Down 7% – Should You Sell?
Falcon Capital Acquisition (OTCMKTS:FCACU) Stock Price Down 7% – Should You Sell?
Falcon Capital Acquisition Is A SPAC Redemption Arbitrage Opportunity
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Falcon Capital Acquisition Corp. - FCAC